ASCO 2014: Dr. Kipps Discusses Targeted Therapy and Obinutuzumab in the Treatment of CLL (chronic lymphocytic leukemia) in my latest blog post at bkoffman.blogspot.com where I reference the latest research and the data from ASH last December.
ASCO 2014: Dr. Kipps Discusses Targeted Therap... - CLL Support
ASCO 2014: Dr. Kipps Discusses Targeted Therapy and Obinutuzumab
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
ASH 2018: Dr. Kipps on antibodies and Venetoclax resistance
first part of my interview with Dr. Kipps at ASH 2018, he discusses resistance and how to possibly...
ASH 2013: Dr. John Pagel Discusses Radio-Immune Therapy (RIT) in Chronic Lymphocytic Leukemia (CLL)
another interview from ASH 2013 that I just posted on my blog http://bkoffman.blogspot.com , Dr....
End of suspense! Here is Dr. Koffman's ASCO 2020 \"Top Pick\" #1!
patients with chronic lymphocytic leukemia (CLL). https://cllsociety.org/2020/08/asco-2020-top-12-1-
Has anyone been on the combination therapy of Venetoclax, Ibrutinib and Obinutuzumab?
could hear from someone who has had the combination of Venetoclax, Ibrutinib and Obinutuzumab...